LINC01587

Across TCGA pan-cancer cohorts, LINC01587 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated LINC01587 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher LINC01587 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01587 expression acts as an unfavorable survival marker, although some lineages such as UCEC and PDAC show a favorable association.

CCRCC, UCEC, and GBM are the cancer types where LINC01587 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	III,IV	0.349	1.000	.006	14	view →
UCEC	OS	Median	III,IV	1.000	0.479	.031	4	view →
GBM	DFS	Tertile	All	0.718	0.905	.043	1	view →
PDAC	DFS	Median	III,IV	1.000	0.627	.040	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

LINC01587–CCRCC (DFS)

Open the CCRCC breakdown →